AI Terminal
Convatec Group PLC
Director's Dealing • May 3, 2023
4959_dirs_2023-05-03_76a8bf22-47cb-4672-b22b-3500419e036b.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
Convatec Group PLC (CTEC)
Convatec Group PLC: Director/PDMR Shareholding
03-May-2023 / 14:10 GMT/BST
3 May 2023
Convatec Group Plc
(“Convatec” or “the Company”)
Director/ PDMR Shareholding
The Company has been notified of the following transactions in relation to a Person Discharging Managerial Responsibility (“PDMR”) in respect of ordinary shares of 10 pence each in the Company (“Shares”).
Shares awarded to Karim Bitar, the Company’s Chief Executive Officer on 1 May 2020 under the Company’s Long Term Incentive Plan (“LTIP”), vested on 2 May 2023 resulting in Karim receiving 911,191 Shares.
On the same date, 429,441 of these Shares were sold automatically on Karim’s behalf to satisfy income tax and national insurance liabilities arising in connection with the vesting of this award.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Karim Bitar | ||
| 2 | Reason for the notification | |||
| a) | Position/Status | Chief Executive Officer and PDMR | ||
| b) | Initial notification/Amendment | Initial notification | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | Convatec Group Plc | ||
| b) | LEI | 213800LS272L4FIDOH92 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary share of 10p each in Convatec Group Plc GB00BD3VFW73 |
||
| b) | Nature of the transaction | Vesting of an award under the Company’s LTIP, granted on 1 May 2020 | ||
| c) | Price(s) and volume(s) | Price(s) n/a |
Volume(s) 911,191 |
|
| d) | Aggregated information - Aggregated volume - Price |
N/A N/A |
||
| e) | Date of the transaction | 2023-05-02 | ||
| f) | Place of the transaction | Outside a trading venue | ||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Karim Bitar | ||
| 2 | Reason for the notification | |||
| a) | Position/Status | Chief Executive Officer and PDMR | ||
| b) | Initial notification/Amendment | Initial notification | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | Convatec Group Plc | ||
| b) | LEI | 213800LS272L4FIDOH92 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary share of 10p each in Convatec Group Plc GB00BD3VFW73 |
||
| b) | Nature of the transaction | Sale of shares arising from the vesting of the share award under the LTIP, to meet income tax and social security liabilities due on vesting | ||
| c) | Price(s) and volume(s) | Price(s) 2.164392 |
Volume(s) 429,441 |
|
| d) | Aggregated information - Aggregated volume - Price |
n/a n/a |
||
| e) | Date of the transaction | 2023-05-02 | ||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||
Enquiries
Louise Bryson, Assistant Company Secretary +44(0)7423 694919
Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com.
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
| ISIN: | GB00BD3VFW73 |
| Category Code: | DSH |
| TIDM: | CTEC |
| LEI Code: | 213800LS272L4FIDOH92 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 241188 |
| EQS News ID: | 1623609 |
| End of Announcement | EQS News Service |